Search results
Ocugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why
Zacks via Yahoo Finance· 5 days agoSome other top-ranked stocks in the healthcare sector are Krystal Biotech, Inc. KRYS, ALX Oncology...
Soaring success: BrainAlive AI's MVP ignites rapid expansion
CryptoNewsZ.com· 3 days agoBrainAlive AI (BAAI) is a deep tech firm committed to developing innovative products that leverage neuroscience, computer vision, and natural language processing (NLP) to ...
Goldman initates Medtronic Plc
Knox Daily· 6 days agoBefore that, Wall Brett A. sold 4,997 shares. Medtronic Plc shares valued at $410,603 were divested by the EVP & Pres Neuroscience at a price of $82.17 per share. As a result ...
Millennials have a favorite parenting style. It isn't working.
INSIDER via Yahoo News· 4 days agoMary Benedetti, a Toronto social worker and psychotherapist who works with children and families,...
What scabs, earwax and tears are trying to tell you | CNN
CNN.com· 2 days agoCNN is showcasing the work of The Conversation, a collaboration between journalists and academics to...
NextSense Honored as World Economic Forum Technology Pioneer
Yucaipa News Mirror· 3 days agoNextSense is proud to announce that it has been recognized as a World Economic Forum Technology...
Jacob Trouba Mentions Grayson Murray Suicide in Response to Critic
US Weekly· 2 days agoIn a clip he shared via X on May 31, Eshghi criticized Trouba as a player, then attacked him as the...
J&J-backed Rapport Therapeutics raises $136 million in US IPO
WHTC 1450 Holland· 3 days ago(Reuters) - Rapport Therapeutics said on Thursday that it has raised $136 million in its initial public offering in the United States at a valuation of about $601.4 million. The company said ...
The Potential Benefits and Dangers of Rewiring the Brain
Mercola· 2 days agoThe panel includes neuroscientists Takao Hensch and John Krakauer, as well as entrepreneur Brett Wingeier, co-founder and CEO of Magnus Medical. This capacity could potentially heal depression ...
Vir Biotechnology (VIR) Up on Positive Data From HDV Study
Zacks via Yahoo Finance· 3 days agoVir Biotechnology (VIR) rises on upbeat data from its phase II study evaluating tobevibart and...